Similar articles

• [Biological markers for diagnosis of Alzheimer's disease].

  Takeda M, Tanaka T, Kudo T, Okochi M, Kamino A, Tagami S. Takeda M, et al. Seishin Shinkeigaku Zasshi. 2004;106(12):1610-4. Seishin Shinkeigaku Zasshi. 2004. PMID: 15770965 Review. Japanese. No abstract available.
• Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

  Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P. Parnetti L, et al. Biol Psychiatry. 2008 Nov 15;64(10):850-5. doi: 10.1016/j.biopsych.2008.02.016. Epub 2008 Apr 8. Biol Psychiatry. 2008. PMID: 18395699
• [Biomarkers in cerebrospinal fluid and blood in memory complaints].

  Zetterberg H, Andreasen N, Blennow K. Zetterberg H, et al. Lakartidningen. 2009 May 13-19;106(20):1386-9. Lakartidningen. 2009. PMID: 19585836 Review. Swedish. No abstract available.
• CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.

  Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K. Smach MA, et al. Neurosci Lett. 2008 Aug 1;440(2):145-9. doi: 10.1016/j.neulet.2008.05.076. Epub 2008 May 24. Neurosci Lett. 2008. PMID: 18555606
• [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].

  Smach MA, Charfeddine B, Lammouchi T, Dridi H, Ben Othman L, Bennamou S, Limem K. Smach MA, et al. Ann Biol Clin (Paris). 2008 Sep-Oct;66(5):531-5. doi: 10.1684/abc.2008.0265. Ann Biol Clin (Paris). 2008. PMID: 18957342 French.